These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20309937)

  • 1. The leader peptide of a human rec. MnSOD as molecular carrier which delivers high amounts of Cisplatin into tumor cells inducing a fast apoptosis in vitro.
    Borrelli A; Schiattarella A; Mancini R; Morelli F; Capasso C; De Luca V; Gori E; Mancini A
    Int J Cancer; 2011 Jan; 128(2):453-9. PubMed ID: 20309937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular carrier to transport and deliver cisplatin into endometrial cancer cells.
    Borrelli A; Schiattarella A; Musella A; Mancini R; Capasso C; De Luca V; Carginale V; Sanseverino M; Tornesello AL; Gori E; Pica A; Di Santi A; Basile F; Iacobellis F; Colacurci N; Cobellis L; Mancini A
    Chem Biol Drug Des; 2012 Jul; 80(1):9-16. PubMed ID: 22260094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new hexapeptide from the leader peptide of rMnSOD enters cells through the oestrogen receptor to deliver therapeutic molecules.
    Borrelli A; Schiattarella A; Mancini R; Pica A; Pollio ML; Ruggiero MG; Bonelli P; De Luca V; Tuccillo FM; Capasso C; Gori E; Sanseverino M; Carpentieri A; Birolo L; Pucci P; Rommelaere J; Mancini A
    Sci Rep; 2016 Jan; 6():18691. PubMed ID: 26725847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical and biochemical characterization of a liposarcoma-derived recombinant MnSOD protein acting as an anticancer agent.
    Mancini A; Borrelli A; Schiattarella A; Aloj L; Aurilio M; Morelli F; Pica A; Occhiello A; Lorizio R; Mancini R; Sica A; Mazzarella L; Sica F; Grieco P; Novellino E; Pagnozzi D; Pucci P; Rommelaere J
    Int J Cancer; 2008 Dec; 123(11):2684-95. PubMed ID: 18798256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells.
    Borrelli A; Schiattarella A; Mancini R; Morrica B; Cerciello V; Mormile M; d'Alesio V; Bottalico L; Morelli F; D'Armiento M; D'Armiento FP; Mancini A
    Free Radic Biol Med; 2009 Jan; 46(1):110-6. PubMed ID: 18996183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rMnSOD on survival signaling in pediatric high risk T-cell acute lymphoblastic leukaemia.
    Pica A; Di Santi A; D'angelo V; Iannotta A; Ramaglia M; Di Martino M; Pollio ML; Schiattarella A; Borrelli A; Mancini A; Indolfi P; Casale F
    J Cell Physiol; 2015 May; 230(5):1086-93. PubMed ID: 25294747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutral Sphingomyelinase Modulation in the Protective/Preventive Role of rMnSOD from Radiation-Induced Damage in the Brain.
    Cataldi S; Borrelli A; Ceccarini MR; Nakashidze I; Codini M; Belov O; Ivanov A; Krasavin E; Ferri I; Conte C; Patria FF; Traina G; Beccari T; Mancini A; Curcio F; Ambesi-Impiombato FS; Albi E
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer activity of a trans-platinum(II) complex of 3-aminoflavone to ovarian cancer cells.
    Orzechowska M; Fabijańska M; Ochocki J; Małecki M
    Ginekol Pol; 2017; 88(2):68-74. PubMed ID: 28326515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional role of MnSOD as a biomarker of human diseases and therapeutic potential of a new isoform of a human recombinant MnSOD.
    Borrelli A; Schiattarella A; Bonelli P; Tuccillo FM; Buonaguro FM; Mancini A
    Biomed Res Int; 2014; 2014():476789. PubMed ID: 24511533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer and chemosensitizing effects of 2,3-DCPE in ovarian carcinoma cell lines: link with ERK activation and modulation of p21WAF1/CIP1, Bcl-2 and Bcl-xL expression.
    Villedieu M; Briand M; Duval M; Héron JF; Gauduchon P; Poulain L
    Gynecol Oncol; 2007 May; 105(2):373-84. PubMed ID: 17276501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
    Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
    Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC
    Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway.
    Wu YJ; Muldoon LL; Neuwelt EA
    J Pharmacol Exp Ther; 2005 Feb; 312(2):424-31. PubMed ID: 15496615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the chemotherapeutic effects of a propadiene compound on malignant ovarian cancer cells.
    Li S; Yang L; Wang J; Liang F; Chang B; Gu H; Wang H; Yang G; Chen Y
    Oncotarget; 2016 Aug; 7(35):57145-57159. PubMed ID: 27494891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmonella enhance chemosensitivity in tumor through connexin 43 upregulation.
    Chang WW; Lai CH; Chen MC; Liu CF; Kuan YD; Lin ST; Lee CH
    Int J Cancer; 2013 Oct; 133(8):1926-35. PubMed ID: 23558669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin induces programmed death-1-ligand 1(PD-L1) over-expression in hepatoma H22 cells via Erk /MAPK signaling pathway.
    Qin X; Liu C; Zhou Y; Wang G
    Cell Mol Biol (Noisy-le-grand); 2010 Sep; 56 Suppl():OL1366-72. PubMed ID: 20937224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ERK1/2 kinase in cisplatin-induced apoptosis in human ovarian carcinoma cells.
    Wei SQ; Sui LH; Zheng JH; Zhang GM; Kao YL
    Chin Med Sci J; 2004 Jun; 19(2):125-9. PubMed ID: 15250250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of Zengmian Yiliu Recipe combined cisplatin on the tumor inhibition rate in platinum-resistant ovarian cancer].
    Qi C; Zhang QH; Li JX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jun; 32(6):817-21. PubMed ID: 22978111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway.
    Jelínková I; Šafaříková B; Vondálová Blanářová O; Skender B; Hofmanová J; Sova P; Moyer MP; Kozubík A; Kolář Z; Ehrmann J; Hyršlová Vaculová A
    Biochem Pharmacol; 2014 Dec; 92(3):415-24. PubMed ID: 25285768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase.
    DeHaan RD; Yazlovitskaya EM; Persons DL
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):383-8. PubMed ID: 11761456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.